Evidence map›Paper›PMID 16892826›Full record

ArticleNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia2006

[Telemedicine and follow up of peritoneal dialysis patients].

P Gallar, M Gutiérrez, O Ortega, I Rodríguez, A Oliet, J C Herrero, C Mon, M Ortiz, A Molina, A Vigil

Registry-linked trialAbstract readEnglish Abstract
PubMed
In one paragraph

Article in Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04034966 (Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04034966 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis

TypeinterventionalSponsorCoordinación de Investigación en Salud, MexicoRan2019 to 2020Enrolled750ConditionsChronic Kidney Disease Stage 5, Peritoneal Dialysis ComplicationArmsClaria telemedicine device
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2021
    Review
  5. Informatic nephrology.International urology and nephrology · 2013
    Review
  6. Article
  7. Article
  8. Telemedicine and Remote Monitoring: Supporting the Patient on Peritoneal Dialysis.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

P GallarServicio de Nefrología, Hospital Severo Ochoa, Madrid. pgallar.hsvo@salud.madrid.org
M Gutiérrez
O Ortega
I Rodríguez
A Oliet
J C Herrero
C Mon
M Ortiz
A Molina
A Vigil

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledMean-term experience in the use of Telemedicine in Peritoneal Dialisis (PD) patients is limited as well as its cost-benefit. The main objective of this work is to evaluate Telemedicine utility in mean-long term control of stable PD patients, analyzing if the televisit (TV) could substitute 50% of the programed inhospital consults (HC) the time spent in both visit modalities, the quality of patient-personel contact as well as how image and sound have been perceived. Visit resolution was analyzed taking into account the need of HC after a TV; We also have studied if it would be possible to retrain patients in the dialisis technique with telemedicine, and we have checked the patient perceived quality and calculate the real and social costs.

methodsduring 18 months, the system has been implanted to 19 patients with 7 +/- 4 follow up (range 3-17). A Falcon videoconference kit at patient's place was used, connected to the home television set. In the hospital there was a computer with a videoconference card, webcam and software meeting point which permits the control of patient's camera from the hospital. Both are connected by a 3RDSI line system. A monthly programmed HC or TV has been made. If more controls had been required, they have been made by TV Time spent was recorded on each TV and patients and staff questionary were inquired.

results(a) PATIENTS: mean age 44 +/- 8 years, 13 (68%) male. 12 (63%) had elemental educational level and 7 (37%) mean-superior. 17 (89%) were actively working. The PD technique was: CAPD 6 (32%) and APD13 (68%). (b) Televisits: 103 TV have been made. 22 +/- 9 minutes were spent on each TV less than in the HC, 33 +/- 8 minutes (p < 0.01). There were technical problems related with lines in 21 TV, but only in 4 the connection was not possible. 92 TV (89%) were made on time, 99 (96%) had a good image quality and 96 (93%) had a correct sound. 100% of patients perceived TV as close to HC. In 90 TV (87%) medical treatment was modified. Only in 4 cases (3.9%) patients needed an hospital visit. According to patient's valuation, TV replaced correctly to HC in 97 instances (94%) and in 97 (97%) in staff opinion. In all cases (100%) catheter exit site could be evaluated as well as edema presence. Retraining was possible in all cases. There was a save in nurse's time and patient's time and also, a save in physical hospital space. Initial investment apart, the daily cost increment was scarce (1.5 Euro) taking into account that there is a save in time for patients and personnel, save in physical space in hospital and in sanitary transport.

conclusionTelemedicine is useful from the clinical point of view in the mean-term for stable patients in PD. Daily cost increment is scarce and there is a save in time for patients and personnel, save in physical space in hospital and in sanitary transport.

Indexed as

Peritoneal DialysisTelemedicineAdultFemaleFollow-Up StudiesHumansMaleTime Factors

Identifiers

PMID16892826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.